Eliminating the Ant1 isoform produces a mouse with CPEO pathology but normal ocular motility

Investigative Ophthalmology and Visual Science

Volumn 46, Issue 12, 2005, Pages 4555-4562

  Yin, Hang ^a   Stahl, John S ^b,c   Andrade, Francisco H ^d   McMullen, Colleen A ^d   Webb Wood, Sarah ^e   Newman, Nancy J ^e   Biousse, Valerie ^e   Wallace, Douglas C ^f   Pardue, Machelle T ^a,e  

^a ATLANTA VA MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^d UNIVERSITY OF KENTUCKY   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE NUCLEOTIDE TRANSLOCASE; ISOPROTEIN; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANT1 GENE; ARM MUSCLE; ARTICLE; CARDIOMYOPATHY; CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; CONTROLLED STUDY; DISEASE MODEL; EXTRAOCULAR MUSCLE; EYE MOVEMENT; GENE; GENE EXPRESSION; GENE MUTATION; KNOCKOUT MOUSE; LEG MUSCLE; MITOCHONDRIAL MYOPATHY; MOUSE; MUSCLE CONTRACTILITY; MUSCLE FATIGUE; MUSCLE FUNCTION; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PATHOLOGY; PRIORITY JOURNAL; ANIMAL; ELECTRON MICROSCOPY; GENE DELETION; GENETICS; METABOLISM; MOUSE MUTANT; MUSCLE MITOCHONDRION; ULTRASTRUCTURE;

ADENINE NUCLEOTIDE TRANSLOCATOR 1; ANIMALS; DISEASE MODELS, ANIMAL; EYE MOVEMENTS; GENE DELETION; MICE; MICE, KNOCKOUT; MICROSCOPY, ELECTRON; MITOCHONDRIA, MUSCLE; MITOCHONDRIAL MYOPATHIES; OCULOMOTOR MUSCLES; OPHTHALMOPLEGIA, CHRONIC PROGRESSIVE EXTERNAL; OXIDATIVE PHOSPHORYLATION; PROTEIN ISOFORMS; RNA, MESSENGER;

EID: 33644807657     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.05-0695     Document Type: Article

References (28)

1. Aasly J, Lindal S, Torbergen T, et al. Early mitochondrial changes in chronic progressive ocular myopathy. Eur Neur. 1990;30:314-318.
2. Caita A, D'Adda T, Carrara F, Zeviani M. Ultrastructural analysis of extraocular muscle in chronic progressive external ophthalmoplegia. Arch Ophthalmol. 2000;118:1441-1445.
3. Kaukonen J, Juselius JK, Tiranti V, et al. Role of adenine nucleotide translocator 1 in mtDNA maintenance. Science. 2000;289:782-785.
4. Silicano G, Tessa A, Petrini S, et al. Autosomal dominant external ophthalmoplegia and bipolar affective disorder associated with a mutation in the ANT1 gene. Neuromuscul Disord. 2003;13:162-165.
5. Agostino A, Valletta L, Chinnery PF, et al. Mutations of ANT1, Twinkle, and POLG1 in sporadic progressive external ophthalmoplegia. Neurology. 2003;60:1354-1356.
6. Graham B, Waymire K, Cottrell B, et al. A mouse model for mitochondrial myopathy and cardiomyopathy resulting from a deficiency in the heart/muscle isoform of the adenine nucleotide translocator. Nat Genet. 1997;16:226-234.
7. Yee RD, Cogan DG, Zee DS, et al. Rapid eye movements in myasthenia gravis. Arch Ophthalmol. 1976;94:1465-1472.
8. Yee RD, Whitcup SM, Williams IM, et al. Saccadic eye movements in myasthenia gravis. Ophthalmology. 1987;94:219-225.
9. Porter JD, Baker RS. Muscles of a different 'color': the unusual properties of the extraocular muscles may predispose or protect them in neurogenic and myogenic disease. Neurology. 1996;46:30-37.
10. Andrade FH, Porter JD, Kaminski HJ. Eye muscle sparing by the muscular dystrophies: lessons to be learned? Microsc Res Tech. 2000;48:192-203.
11. Stahl JS, van Alphen AM, De Zeeuw CI. A comparison of video and magnetic search coil recordings of mouse eye movements. J Neurosci Methods. 2000;99:101-110.
12. Stahl JS. Calcium channelopathy mutants and their role in ocular motor research. Ann N Y Acad Sci. 2002;956:64-74.
13. Stahl JS. Eye movements of the murine P/Q calcium channel mutant rocker, and the impact of aging. J Neurophysiol. 2004;91:2066-2078.
14. Baloh R, Keesey J. Saccade fatigue and response to edrophonium for the diagnosis of myasthenia gravis. Ann N Y Acad Sci. 1976;274:631-641.
15. Spooner JW, Baloh RW. Eye movement fatigue in myasthenia gravis. Neurology. 1979;29:29-33.
16. Barton JJS, Huaman AG, Sharpe JA. Effects of edrophonium on saccadic velocity in normal subjects and myasthenic and nonmyasthenic ocular palsies. Ann Neurol. 1994;36:585-594.
17. McMullen CA, Andrade FH, Stahl JS. Functional and genomic changes in the mouse ocular motor system in response to light deprivation from birth. J Neurosci. 2004;24:161-169.
18. Giulietti A, Overbergh L, Valckx D, et al. An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. Methods. 2001;25:386-401.
19. ΔΔCt method. Methods. 2001;25:402-408.
20. Carry MR, Ringel SP, Starcevich JM. Mitochondrial morphometrics of histochemically identified human extraocular muscle fibers. Anat Rec. 1986;214:8-16.
21. Carry MR, O'Keefe K, Ringel SP. Histochemistry of mouse extraocular muscle. Anat Embryol. 1982;164:403-412.
22. Stahl JS, Averbuch-Heller L, Render BF, Leigh RJ. Clinical evidence of extraocular muscle fiber-type specificity of botulinum toxin. Neurology. 1998;51:1093-1099.
23. Barton JJ, Sharpe JA. 'Saccadic jitter' is a quantitative ocular sign in myasthenia gravis. Invest Ophthalmol Vis Sci. 1995;36:1566-1572.
24. Levy SE, Chen YS, Graham BH, Wallace DC. Expression and sequence analysis of the mouse adenine nucleotide translocase 1 and 2 genes. Gene. 2000;254:57-66.
25. Leigh RJ, Zee DS. The Neurology of Eye Movements. New York: Oxford University Press; 1999.
26. Optican LM, Robinson DA. Cerebellar-dependent adaptive control of primate saccadic system. J Neurophysiol. 1980;44:1058-1076.
27. Porter JD, Merriam AP, Hack AA, et al. Extraocular muscle is spared despite the absence of an intact sacroglycan complex in γ- or δ-sacroglycan-deficient mice. Neuromuscul Disord. 2000;11:197-207.
28. Porter JD, Rafael JA, Ragusa RJ, et al. The sparing of extraocular muscle in dystrophinopathy is lost in mice lacking utrophin and dystrophin. J Cell Science. 1998;111:1801-1811.